Background Gut bacteria have been implicated in a wide range of health conditions, yet their potential role in preventing and treating muscle-wasting disorders remains largely unexplored. Objective We ...

2 Departments of Biochemistry and Medical Microbiology and Immunology, Li Ka Shing Insitute of Virology, University of Alberta, Edmonton, Alberta, Canada Objective Hepatitis C virus (HCV) infection ...

An 82-year-old man with alcohol-related cirrhosis (Child-Pugh class B), complicated by portal hypertension and a history of partial gastrectomy with Billroth I reconstruction for duodenal ulcer ...

Correspondence to Professor Giovanni Targher, Endocrinology and Metabolism, University of Verona Department of Medicine, Verona 37126, Italy; giovanni.targher{at}univr.it Non-alcoholic fatty liver ...

Objective To gain mechanistic insights, we compared effects of low fermentable oligosaccharides, disaccharides and monosaccharides and polyols (FODMAP) and high FODMAP diets on symptoms, the ...

1 Department of Clinical and Experimental Medicine, Translational Research Center for Gastrointestinal Disorders (TARGID), University of Leuven, Leuven, Belgium 2 Department of Gastroenterology, ...

Introduction The management of chronic constipation remains challenging, with high rates of treatment dissatisfaction. Current clinical guidelines included limited dietary recommendations, and there ...

Liver fibrosis should be assessed in all individuals with chronic liver disease as it predicts the risk of future liver-related morbidity and thus need for treatment, monitoring and surveillance.

1 Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA, and Harvard Medical School, Boston, MA, USA 2 ...

3 School of Medicine, University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia Correspondence to Dr Erin R Shanahan, Gastroenterology Research, Level 5, ...

Background Concomitant metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent in patients with chronic ...

Background PD-1 blockade has emerged as a promising approach for functional cure of chronic hepatitis B (CHB). Objective This study aimed to evaluate the safety profile of anti-PD-1 antibody (αPD-1), ...